An article published in Becker’s Hospital Review referenced a study published in the November 2023 issue of The American ...

The withdrawal of aid related to addressing the worldwide HIV/AIDS epidemic provided by the US through the President’s Emergency Plan for AIDS Relief (PEPFAR) could lead to the loss of millions of ...

Recent FDA approvals include new therapies for AD, HS, and plaque psoriasis, impacting patients with skin of color. Tapinarof cream, roflumilast foam, and delgocitinib are notable topical treatments ...

The government shutdown highlights partisan divisions over health care funding, with Democrats pushing for ACA subsidy ...

Mark Riggle, PharmD, assistant chief pharmacist at UC Davis, discussed different programs that help to provide accessible ...

The researchers concluded that those who younger than 3 years benefited from receiving 2 doses of IIV in the first year of influenza vaccination, receiving more protection than those who receibed 1 ...

His study, "Impact of More Primary Care Visits on Commercial Health Care Costs," found that more frequent routine primary ...

Prescription digital therapeutics (PDTs) are FDA-regulated tools that deliver evidence-based interventions via software, and ...

Reducing data silos and boosting transparency in oncology requires payer-provider trust and co-governance, according to Vishnukamal Golla, MD, MPH.

This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.

Planetary health links human well-being with ecosystem health, emphasizing biodiversity loss as a driver of respiratory ...

The FDA Thursday approved generic mifepristone 200-mg tablets (Evita Solutions), potentially paving the way for a more accessible version of the branded drug (Mifeprex; Danco Laboratories) but also ...